Table 3 Quality of life evaluation - SF-36.
From: Dyspnea and quality of life in patients referred for lung transplantation
PF | RP | BP | GH | VIT | |
|---|---|---|---|---|---|
Total | 19.3 ± 15.9 | 16.2 ± 22.6 | 48.8 ± 27.1 | 25.9 ± 11.9 | 37.5 ± 17.0 |
IPF | 19.1 ± 17.0 | 20.7 ± 23.2 | 47.3 ± 25.9 | 28.5 ± 10.7 | 38.7 ± 19.8 |
COPD | 24.3 ± 18.8 | 8.0 ± 14.0 | 54.0 ± 27.2 | 27.7 ± 13.3 | 35.4 ± 14.4 |
IIP | 16.1 ± 12.1 | 16.9 ± 25.1 | 46.7 ± 28.5 | 22.5 ± 11.4 | 37.7 ± 16.2 |
SF | RE | MH | PCS | MCS | |
Total | 33.0 ± 24.6 | 35.6 ± 36.8 | 47.6 ± 21.4 | 25.8 ± 7.3 | 39.6 ± 13.6 |
IPF | 33.4 ± 26.0 | 40.3 ± 36.9 | 49.2 ± 22.8 | 25.9 ± 7.8 | 42.4 ± 14.2 |
COPD | 37.9 ± 29.0 | 32.4 ± 38.8 | 51.7 ± 18.8 | 25.1 ± 8.3 | 37.8 ± 15.3 |
IIP | 29.4 ± 20.1 | 33.2 ± 36.2 | 43.6 ± 21.7 | 26.0 ± 6.3 | 38.2 ± 12.1 |